ExLibris header image
SFX Logo
Title: Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoprotein
Source:

Science [0036-8075] Lasky, L A yr:1986


Collapse list of basic services Basic
Sorry, no full text available...
Please use the document delivery service (see below)  
Holding information
Holdings in library search engine ALBERT GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Dalziel, Christopher A. "Emerging principles for the therapeutic exploitation of glycosylation." Science 343.6166 (2014): 1235681-1235681. Link to SFX for this item
2. Robey, W G G. "Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibody." Proceedings of the National Academy of Sciences of the United States of America 83.18 (1986): 7023-7. Link to Full Text for this item Link to SFX for this item
3. Vaine, M. "Antibody responses elicited through homologous or heterologous prime-boost DNA and protein vaccinations differ in functional activity and avidity." Vaccine 28.17 (2010): 2999-3007. Link to SFX for this item
4. Fenouillet, E. "Functions of HIV envelope glycans." Trends in biochemical sciences 19.2 (1994): 65-70. Link to Full Text for this item Link to SFX for this item
5. Crispin, M. "Targeting host-derived glycans on enveloped viruses for antibody-based vaccine design." Current Opinion in Virology 11 (2015): 63-69. Link to SFX for this item
6. Moremen, Kelley W. "Vertebrate protein glycosylation: diversity, synthesis and function." Nature reviews. Molecular cell biology 13.7 (2012): 448-462. Link to SFX for this item
7. Hoffman, NG. "Variability in the human immunodeficiency virus type 1 gp120 Env protein." Journal of virology 76.8 (2002): 3852-. Link to Full Text for this item Link to SFX for this item
8. Gnann, John W. "Diagnosis of AIDS by using a 12-amino acid peptide representing an immunodominant epitope of the human immunodeficiency virus." The journal of infectious diseases 156.2 (1987): 261-267. Link to SFX for this item
9. Huang, X. "Mucosal priming with replicative Tiantan vaccinia and systemic boosting with DNA vaccine raised strong mucosal and systemic HIV-specific immune responses." Vaccine 25.52 (2007): 8874-. Link to SFX for this item
10. McCune, J M M. "Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus." Cell 53.1 (1988): 55-67. Link to Full Text for this item Link to SFX for this item
11. Gamblin, S. "Influenza Hemagglutinin and Neuraminidase Membrane Glycoproteins." Journal of biological chemistry 285.37 (2010): 28403-28409. Link to Full Text for this item Link to SFX for this item
12. Gilbert, P B B. "Long-term safety analysis of preventive HIV-1 vaccines evaluated in AIDS vaccine evaluation group NIAID-sponsored Phase I and II clinical trials." Vaccine 21.21-22 (2003): 2933-47. Link to SFX for this item
13. Lu, S. "Heterologous prime-boost vaccination." Current opinion in immunology 21.3 (2009): 346-351. Link to SFX for this item
14. Rathore, A. "Quality by design for biopharmaceuticals." Nature biotechnology 27.1 (2009): 26-34. Link to Full Text for this item Link to SFX for this item
15. Dwek, Raymond A. "Targeting glycosylation as a therapeutic approach." Nature reviews. Drug discovery 1.1 (2002): 65-75. Link to Full Text for this item Link to SFX for this item
16. Adis International, L.. "HIV gp120 vaccine - VaxGen: AIDSVAX, AIDSVAX B/B, AIDSVAX B/E, HIV gp120 vaccine - Genentech, HIV gp120 vaccine AIDSVAX - VaxGen, HIV vaccine AIDSVAX - VaxGen." Drugs in R & D 4.4: 249-253. Link to SFX for this item
17. Dwek, Raymond A. "Exploiting the defensive sugars of HIV-1 for drug and vaccine design." Nature 446.7139 (2007): 1038-1045. Link to Full Text for this item Link to SFX for this item
18. Banki, Z. "HIV and human complement: inefficient virolysis and effective adherence." Immunology letters 97.2 SPEC. ISS. (2005): 209-14. Link to SFX for this item
19. Ju, T. "Protein glycosylation in cancer." Annual review of pathology 10.1 (2015): 473-510. Link to Full Text for this item Link to SFX for this item
20. Gill, D. "Location, location, location: new insights into O-GalNAc protein glycosylation." Trends in cell biology 21.3 (2010): 149-158. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced